We are live on
!
Find out more
JC
JBF Capital Portfolio holdings
AUM
$764M
Turnover
38.35%
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter
Est. Return
+4.93%
1 Year Est. Return
+24.26%
3 Year Est. Return
+93.63%
5 Year Est. Return
+127.41%
10 Year Est. Return
+469.69%
AUM
$679M
AUM Growth
+$26.4M
(+4.1%)
Cap. Flow
-$3.91M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
90.88%
Holding
113
New
14
Increased
7
Reduced
10
Closed
23
Avg Time Held
0.6
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$5.11M |
| 2 |
CELG
Celgene Corp
CELG
|
+$4.56M |
| 3 |
AbbVie
ABBV
|
+$3.18M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$3.14M |
| 5 |
Viatris
VTRS
|
+$2.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$4.08M |
| 2 |
Voya Financial
VOYA
|
+$2.87M |
| 3 |
United Parcel Service
UPS
|
+$2.82M |
| 4 |
Bank of America
BAC
|
+$2.33M |
| 5 |
JPMorgan Chase
JPM
|
+$2.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 86% |
| 2 | Financials | 4.81% |
| 3 | Healthcare | 4.69% |
| 4 | Materials | 0.93% |
| 5 | Technology | 0.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $29K | ﹤0.01% |
63
| – | – |
2014 Q1
1 quarter
|
|
77
Harvard Bioscience
HBIO
$37.8M
| $28K | ﹤0.01% |
620
| – | – |
2013 Q4
2 quarters
|
|
78
Vanguard FTSE All-World ex-US ETF
VEU
$67.4B
| $28K | ﹤0.01% |
542
| – | – |
2013 Q2
4 quarters
|
|
79
Radiant Logistics
RLGT
$426M
| $26K | ﹤0.01% |
8,410
| – | – |
2013 Q2
4 quarters
|
|
|
DDE
80
DELISTED
Dover Downs Gaming & Entertain
DDE
| $22K | ﹤0.01% |
16,157
| – | – |
2013 Q2
4 quarters
|
|
81
Star Equity Holdings
STRR
$36.9M
| $19K | ﹤0.01% |
485
| – | – |
2013 Q2
4 quarters
|
|
82
Vanguard FTSE Developed Markets ETF
VEA
$228B
| $18K | ﹤0.01% |
434
| – | – |
2013 Q2
4 quarters
|
|
|
CALL
83
DELISTED
magicJack VocalTec Ltd
CALL
| $15K | ﹤0.01% |
1,000
-24,650
| -96% | -$415K |
2014 Q1
1 quarter
|
|
84
Alpha Pro Tech
APT
$58.4M
| $8K | ﹤0.01% |
3,600
| – | – |
2013 Q2
4 quarters
|
|
|
QCCO
85
DELISTED
QC HLDGS INC
QCCO
| $7K | ﹤0.01% |
2,749
| – | – |
2013 Q2
4 quarters
|
|
|
LUB
86
DELISTED
Luby's Inc.
LUB
| $5K | ﹤0.01% |
900
| – | – |
2013 Q4
2 quarters
|
|
87
US Global Investors
GROW
$33.5M
| $4K | ﹤0.01% |
1,000
| – | – |
2013 Q2
4 quarters
|
|
|
UNTD
88
DELISTED
UNITED ONLINE INC COM NEW
UNTD
| $3K | ﹤0.01% |
328
| – | – |
2013 Q2
4 quarters
|
|
|
DAEG
89
DELISTED
DAEGIS INC
DAEG
| $2K | ﹤0.01% |
1,400
| – | – |
2013 Q2
4 quarters
|
|
90
DELISTED
KEMET Corporation
KEM
| $1K | ﹤0.01% |
100
| – | – |
2013 Q2
4 quarters
|
|
91
Arbutus Biopharma
ABUS
$850M
| – | – |
-60,410
| Closed | -$1.3M | – |
|
|
92
Applied Materials
AMAT
$341B
| – | – |
-200,000
| Closed | -$4.08M | – |
|
93
Banc of California
BANC
$2.73B
| – | – |
-100,000
| Closed | -$1.23M | – |
|
94
DHT Holdings
DHT
$3.78B
| – | – |
-11,396
| Closed | -$89K | – |
|
95
Enanta Pharmaceuticals
ENTA
$334M
| – | – |
-1,139
| Closed | -$46K | – |
|
96
Ford
F
$49.1B
| – | – |
-100,000
| Closed | -$1.56M | – |
|
97
First Financial Bancorp
FFBC
$3.3B
| – | – |
-77,161
| Closed | -$1.39M | – |
|
98
Full House Resorts
FLL
$39.6M
| – | – |
-1,197
| Closed | -$3K | – |
|
99
DELISTED
Fonar
FONR
| – | – |
-1,000
| Closed | -$18K | – |
|
100
Kinder Morgan
KMI
$73.1B
| – | – |
-15,000
| Closed | -$487K | – |
|
Similar funds
UCMOK
EIM
CAAM
KLI
CT
ANRF
NI
HI
JBF Capital's Q2 2014 Portfolio in Review
As of Q2 2014, JBF Capital held 113 positions worth $679M, up 4.1% from $652M the previous quarter. Its ten largest holdings account for 91% of the portfolio.
JBF Capital's Q2 2014 filing shows 14 new, 7 increased, 10 reduced and 23 closed positions. Its largest new stake was Teva Pharmaceutical Industries Limited: 100,000 shares worth $5.24M. The largest sale was Applied Materials, an estimated $4.08M.
By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, up from 86% a quarter earlier, followed by Financials and Healthcare.
- JBF Capital's largest Q2 2014 buy was Teva Pharmaceutical Industries Limited: 100,000 shares worth $5.24M.
- JBF Capital added most to Yahoo Inc in Q2 2014, an estimated $3.14M increase.
- JBF Capital's biggest Q2 2014 reduction was United Parcel Service, cutting an estimated $2.82M.
- JBF Capital fully exited Applied Materials in Q2 2014, selling an estimated $4.08M.
- JBF Capital's ten largest holdings make up 91% of its $679M portfolio in Q2 2014.
- JBF Capital opened 14 new positions and closed 23 in Q2 2014.
- JBF Capital's portfolio value rose 4.1% quarter-over-quarter to $679M.
Based on JBF Capital's 13F filing for Q2 2014, filed 13 Aug 2014.